GSK forms drug discovery alliance with University of California CRISPR researchers Medical Dialogues Bureau14 Jun 2019 12:24 PM ISTBritish drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
Wockhardt gets zero observations from USFDA for bioequivalence centre at Aurangabad Medical Dialogues Bureau14 Jun 2019 10:30 AM ISTDuring the inspection, bioanalytical and quality systems of bioequivalence studies of Tamsulosin 0.4 mg capsules and Metoprolol ER tablets were...
IBM, Walmart, Merck in blockchain collaboration with FDA Medical Dialogues Bureau14 Jun 2019 9:41 AM ISTIBM, Merck and Walmart have been chosen for a U.S. Food and Drug Administration pilot program that will explore using blockchain technology to improve...
Amgen drug shows high response rate in small lung, colon cancer trial Medical Dialogues Bureau14 Jun 2019 9:15 AM ISTWall Street has taken a keen interest in the Amgen drug that could become the first approved medicine targeting a mutated form of a gene known as KRAS...
Canadian advisory council calls for universal public drug coverage Medical Dialogues Bureau14 Jun 2019 9:00 AM ISTThe council said a national drug agency should be created first, with coverage for essential medicines in place by January 1, 2022.OTTAWA: A Canadian...
Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report Medical Dialogues Bureau13 Jun 2019 10:03 AM ISTThe U.S. sued the Novartis six years ago, joining in a case filed by a former sales representative who accused the company of using its speaker's...
Alembic Pharma to raise up to Rs 300 crore via issuance of NDCs Farhat Nasim13 Jun 2019 10:00 AM ISTAlembic Pharma has approved the issue of unsecured listed rated redeemable non-convertible debentures (NCDs) of up to Rs 300 crore on a private...
Emerging drug DS-8201 could soon spell end of chemotherapy: Report Medical Dialogues Bureau13 Jun 2019 9:15 AM ISTAs importantly, its ability to target cancer cells without affecting normal cells is a key advantage over the take-no-prisoners approach of...
Catalyst Pharma files lawsuit against USFDA challenging approval of Ruzurgi Medical Dialogues Bureau13 Jun 2019 9:00 AM ISTRuzurgi was approved last month for treating Lambert-Eaton myasthenic syndrome that affects about one in 100,000 people in the United States.U.S:...
End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS Farhat Nasim12 Jun 2019 11:30 AM ISTIndian drug regulator, the Central Drugs Standard Control Organisation (CDSCO), under the health ministry has proposed that manufacture, sale and...
Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer Medical Dialogues Bureau12 Jun 2019 9:50 AM ISTThe approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 9:30 AM ISTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
